Sialyltransferase activity in tumor tissues. 1984

P G Berge, and A Wilhelm, and H Schriewer

Sialyltransferase (ST) activity was examined in tumor and control tissues. Within each group of control tissues a wide variation in the levels of ST activity was observed. Only in 20% of the tumors was the ST activity above the range of enzyme activity of the corresponding group of control tissues. Compared with its corresponding normal counterpart from the same individual, ST was elevated in tumor tissue by a factor of 2.1 on average. The distribution function indicates an increase in enzyme activity in 74% of the tumors. Other tumor markers were also determined for comparison. The ratio of the lactate dehydrogenase (LDH) subunits (M/H) was increased in tumors by a factor of 1.3 on average; the frequency of increase was 75%. From the distribution function of our data it follows that a decrease in the ratio of the creatine kinase (CK) subunits (B/M) occurs in 56% of tumors, the average factor being 0.8. The Regan isoenzyme of the alkaline phosphatase (AP) could be demonstrated in 13% of the tumors. In serum and in tissues ST was found to be composed of multiple forms. However, an isoenzyme of higher tumor specificity has not yet been established.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D005615 Freezing Liquids transforming into solids by the removal of heat. Melting
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P G Berge, and A Wilhelm, and H Schriewer
January 1982, Leukemia research,
P G Berge, and A Wilhelm, and H Schriewer
July 2012, Veterinary pathology,
P G Berge, and A Wilhelm, and H Schriewer
March 2014, Circulation research,
P G Berge, and A Wilhelm, and H Schriewer
February 1977, Nature,
P G Berge, and A Wilhelm, and H Schriewer
September 1989, International journal of cancer,
P G Berge, and A Wilhelm, and H Schriewer
January 1983, Cancer investigation,
P G Berge, and A Wilhelm, and H Schriewer
December 1983, Nihon Naibunpi Gakkai zasshi,
P G Berge, and A Wilhelm, and H Schriewer
July 1994, The Journal of biological chemistry,
P G Berge, and A Wilhelm, and H Schriewer
September 1977, The Biochemical journal,
Copied contents to your clipboard!